EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognostic Factors in Oropharyngeal Cancer Treated With Definitive Chemoradiotherapy

Sheetal R Kashid, Ashwini Budrukkar iD, Monali Swain, Sarbani Ghosh Laskar iD, Vedang Murthy, Tejpal Gupta, Ajay Sasidharan, Vijay Patil, Amit Joshi, Vanita Noronha, Neha Mittal, Manoj Mahimkar und 8 weitere

Cancer Medicine · 2026-05 · 15 (5)

DOI: 10.1002/cam4.71854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 13.05.2026. Verfasst von Sheetal R Kashid und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Chemoradiotherapy. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tata Memorial Centre, Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

HPV‐negative oropharyngeal squamous cell cancer (OPSCC) is associated with poor clinical outcomes. The main objective of this study was to evaluate prognostic factors of OPSCC treated with definitive chemoradiotherapy (CTRT). Materials and Methods Consecutive patients of OPSCC treated with definitive CTRT in a tertiary care center from January 2013 to December 2017 were analysed retrospectively. Kaplan–Meier method was used for survival analysis, Log‐rank test was used for univariate analysis (UVA), and Cox regression method was used for multivariate analysis (MVA).

Results

Out of 630 eligible patients, 543 (86.1%) had locally advanced stage according to AJCC 7 th edition. HPV status was known for 500 patients, of which 55 (11%) tested p16 positive, reflecting a predominantly HPV‐negative cohort. Chemo‐radiotherapy was offered to 447 (71%) patients. Intensity‐modulated‐radiotherapy (IMRT) technique was used for 163 (25.9%) patients. On UVA KPS ≤ 80 ( p = 0.001), p16 negative tumours ( p < 0.001), T3‐T4 stage ( p < 0.001), advanced group stage (AJCC 8 th ed.) ( p < 0.001), conventional RT technique ( p < 0.001), RT dose < 66 Gy EQD2 ( p < 0.001) and residual disease after treatment ( p < 0.001) were associated with poor Locoregional control (LRC) rates. On MVA p16 negative tumours (HR 3.1 [95% CI 1.8–5.3]), T3‐T4 stage (HR 1.6 [95% CI 1.2–2.2]), conventional RT technique (HR 1.6 [95% CI 1.5–2.3]), RT dose < 66 Gy EQD2 (HR 2.2 [95% CI 1.5–3.4]) were independent prognostic factors for poor LRC. These variables were also significant for local control, disease‐free free and overall survival.

Conclusion

In this predominantly HPV‐negative OPSCC cohort, HPV status, T stage, RT technique, and RT doses > 66 Gy were independent prognostic factors for all outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oropharyngeal NeoplasmsChemoradiotherapyHumansFemaleMalePrognosisRetrospective StudiesMiddle AgedAgedNeoplasm StagingAdultTreatment OutcomeKaplan-Meier EstimateRadiotherapy, Intensity-ModulatedPapillomavirus InfectionsHuman Papillomavirus Viruses

Stichwörter der Autor:innen

HPVHPV negative oropharyngeal cancerchemoradiotherapyhead and neck oncologyhead and neck squamous cell carcinomahuman papillomavirusoral canceroropharyngeal cancer

Autor:innen und Institutionen

  • Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Mahimkar Lab, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
  • Homi Bhabha National Institute, Mumbai, India.

ORCID-Profile: Ashwini Budrukkar, Sarbani Ghosh Laskar, Jai Prakash Agarwal

Förderung

  • Tata Memorial Centre
  • Council of Scientific and Industrial Research, India

Zitieren

APA

Kashid, S. R., Budrukkar, A., Swain, M., Laskar, S. G., Murthy, V., Gupta, T., Sasidharan, A., Patil, V., Joshi, A., Noronha, V., Mittal, N., Mahimkar, M., Patil, A., Patel, U., Sinha, S., Kumar, A., Menon, N., Bal, M., Prabhash, K., & Agarwal, J. P. (2026). Prognostic Factors in Oropharyngeal Cancer Treated With Definitive Chemoradiotherapy. Cancer Medicine, 15(5). https://doi.org/10.1002/cam4.71854

Vancouver

Kashid SR, Budrukkar A, Swain M, Laskar SG, Murthy V, Gupta T, et al. Prognostic Factors in Oropharyngeal Cancer Treated With Definitive Chemoradiotherapy. Cancer Medicine. 2026;15(5). doi:10.1002/cam4.71854

BibTeX
@article{Kashid2026,
  author = {Kashid, Sheetal R and Budrukkar, Ashwini and Swain, Monali and Laskar, Sarbani Ghosh and Murthy, Vedang and Gupta, Tejpal and Sasidharan, Ajay and Patil, Vijay and Joshi, Amit and Noronha, Vanita and Mittal, Neha and Mahimkar, Manoj and Patil, Asawari and Patel, Usha and Sinha, Shwetabh and Kumar, Anuj and Menon, Nandini and Bal, Munita and Prabhash, Kumar and Agarwal, Jai Prakash},
  title = {Prognostic Factors in Oropharyngeal Cancer Treated With Definitive Chemoradiotherapy},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.1002/cam4.71854}
}
Kostenlos starten →